Aceril Tablet 5 mg

Aceril Tablet is a cardiovascular medication containing Ramipril (5 mg) manufactured by Ibn Sina Pharmaceuticals Ltd. Priced at ৳8.00 per unit (strip: ৳80.00), this tablet effectively manages hypertension, heart failure, and reduces cardiovascular risks in high-risk patients.

As an ACE inhibitor, Aceril Tablet blocks angiotensin II production, relaxing blood vessels and lowering blood pressure. It’s prescribed for post-heart attack care, diabetic nephropathy, and stroke prevention. The dosage ranges from 1.25-20 mg/day based on condition severity, with adjustments for kidney impairment.

Key indications include hypertension management (mono/combination therapy), congestive heart failure, and cardiovascular risk reduction. Store below 30°C, away from light. Common side effects include dizziness and cough, while rare cases may involve angioedema. Avoid during pregnancy and breastfeeding.

For optimal results, follow prescribed Aceril Tablet খাওয়ার নিয়ম: initial doses start at 1.25 mg, gradually increasing under medical supervision. Drug interactions occur with diuretics, NSAIDs, and lithium. Always consult physicians before combining medications.

This cost-effective brand (pack: ৳240.00 for 30 tablets) offers long-term therapeutic benefits. Explore other Ramipril alternatives and cardiovascular treatments at Medexly for comprehensive care solutions.

Initial dose for hypertension: 1.25-2.5 mg/day, max 20 mg/day. Heart failure: Start with 2.5 mg twice daily, titrate upward. Renal impairment: 1.25 mg/day initially. Swallow tablet whole with water, before/after meals. Never adjust dose without medical supervision.

Aceril is generally well tolerated. Dizziness, headache, fatigue and asthenia are commonly reported side effects. Other side effects occurring less frequently include symptomatic hypotension, cough, nausea, vomiting, diarrhoea, rash, urticaria, oliguria, anxiety, amnesia etc. Angioneurotic oedema, anaphylactic reactions and hyperkalaemia have also been reported rarely.

Pregnancy category D. Fetal renal damage risk in 2nd/3rd trimesters. May affect nursing infant’s renal system. Consider alternative therapies if planning pregnancy.

Monitor BUN/creatinine in dehydration. Discontinue 48h pre-surgery. Limit salt intake. Lie down 2-8h after first dose. Biannual renal function tests. Slow dose titration to prevent hypotension.

Elderly: Start with 1.25 mg/day. Renal impairment (CrCl <40 mL/min): halve dose. Liver cirrhosis: max 2.5 mg/day. Pediatric safety unestablished.

Sign and symptom: Overdosage may cause excessive peripheral vasodilatation (with marked hypotension, shock), bradycardia, electrolyte disturbances, and renal failure.

Management: Primary detoxifcation by, for example, gastric lavage, administration of adsorbents, sodium sulfate; (if possible during the frst 30 minutes). In the event of hypotension administration of α1-adrenergic agonists (e.g. norepinephrine, dopamine) or angiotensin II (angiotensinamide), which is usually available only in scattered research laboratories, must be considered in addition to volume and salt substitution.